mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0009 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |